Back to LOOMIS SAYLES & CO L P

REGN
Showing 8 of 30 quarters

Position history for LOOMIS SAYLES & CO L P's holdings in REGENERON PHARMACEUTICALS

LOOMIS SAYLES & CO L P holds 1.9M shares of REGN (REGENERON PHARMACEUTICALS), worth $1.5B as of 2026-Q1. The position was decreased (-1.1% shares). REGN represents 2.0% of LOOMIS SAYLES & CO L P's portfolio.

Current Value

$1.5B

Current Shares

1.9M

Total Value Change

+$198.6M

Total Shares Change

+695,454

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
1.9M
-1.1%
$1.5B2.0%$766.66
0
2025-Q4
Decreased
1.9M
-2.3%
$1.5B1.8%$773.94
0
2025-Q3
Increased
2M
+2.0%
$1.1B1.3%$560.05
51
2025-Q2
Increased
1.9M
+18.6%
$1B1.3%$519.56
59
2025-Q1
Increased
1.6M
+3.9%
$1B1.5%$634.66
52
2024-Q4
Increased
1.6M
+33.4%
$1.1B1.4%$698.71
65
2024-Q3
Decreased
1.2M
-2.9%
$1.2B1.6%$1,036.94
0
2024-Q2
Increased
1.2M
+0.8%
$1.3B1.8%$1,045.23
51

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used